newsfilter
← Latest News
GlobeNewswire·

Cardiff Oncology Announces $10 Million Registered Direct Offering

SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF) (the "Company"), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today